(Q35242200)

English

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group (English)

1 reference

Europe PubMed Central

7 August 2017

0 references

interstitial lung disease

1 reference

based on heuristic

inferred from title

Robert Elashoff

9

object named as

Robert Elashoff

1 reference

Europe PubMed Central

7 August 2017

Donald P Tashkin

12

object named as

Donald P Tashkin

1 reference

Europe PubMed Central

7 August 2017

7

object named as

Michael D Roth

1 reference

Europe PubMed Central

7 August 2017

author name string

Dinesh Khanna

1

1 reference

Europe PubMed Central

7 August 2017

Chi-Hong Tseng

2

1 reference

Europe PubMed Central

7 August 2017

Niloofar Farmani

3

1 reference

Europe PubMed Central

7 August 2017

Virginia Steen

4

1 reference

Europe PubMed Central

7 August 2017

Daniel E Furst

5

1 reference

Europe PubMed Central

7 August 2017

Philip J Clements

6

1 reference

Europe PubMed Central

7 August 2017

Jonathan Goldin

8

1 reference

Europe PubMed Central

7 August 2017

James R Seibold

10

1 reference

Europe PubMed Central

7 August 2017

Rajeev Saggar

11

1 reference

Europe PubMed Central

7 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2011

1 reference

Europe PubMed Central

7 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

7 August 2017

63

1 reference

Europe PubMed Central

7 August 2017

10

1 reference

Europe PubMed Central

7 August 2017

3078-3085

1 reference

Europe PubMed Central

7 August 2017

Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Scleroderma lung disease: evolving understanding in light of newer studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Changes in causes of death in systemic sclerosis, 1972-2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Standardisation of the measurement of lung volumes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183128

12 July 2018

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FART.30467

21 January 2018

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://api.crossref.org/works/10.1002%2FART.30467

21 January 2018

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study

1 reference

https://api.crossref.org/works/10.1002%2FART.30467

21 January 2018

Accuracy of high resolution CT in assessing idiopathic pulmonary fibrosis histology by objective morphometric index.

1 reference

https://api.crossref.org/works/10.1002%2FART.30467

21 January 2018

Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline

1 reference

https://pubmed.ncbi.nlm.nih.gov/21618205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21618205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21618205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.30467

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35242200&oldid=2102383639"